WCM-Q Grand Rounds 'Continuous Glucose Monitoring: Utility in Clinical Practice and a Practical Guide to Interpretation'

RSSAMADHPWebinar

Add to Calendar WCM-Q Grand Rounds 'Continuous Glucose Monitoring: Utility in Clinical Practice and a Practical Guide to Interpretation' 5/25/2025 3:30:00 PM 5/25/2025 4:30:00 PM Asia/Riyadh For More Details: https://wcmq.cloud-cme.com/course/courseoverview?EID=3679 Description: Date:Sunday, May 25, 2025Speaker:Fatih Gurbuz, MDLearning Objectives:At the end of this activity, participants will be able to1. Describe key features and functions of CGM devices.2. Analyze and interpret CGM reports, identifying critical glucose patterns.3. Develop data-driven strategies to optimize glucose management through case-based examples.To be able to register for the activity youMUST firstSign ... Livestreamed (Zoom) false MM/DD/YYYY


Date & Location
Sunday, May 25, 2025, 3:30 PM - 4:30 PM, Livestreamed (Zoom)

Overview

Date: Sunday, May 25, 2025

Speaker: Fatih Gurbuz, MD

Learning Objectives:

At the end of this activity, participants will be able to

1. Describe key features and functions of CGM devices.

2. Analyze and interpret CGM reports, identifying critical glucose patterns.

3. Develop data-driven strategies to optimize glucose management through case-based examples.

 


To be able to register for the activity you MUST first Sign In to the portal.

The registration closes ONE day before the activity. You will receive a UNIQUE link to join the webinar on the day of the presentation.


Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Students

Overall Learning Objective
  1. Describe key features and functions of CGM devices.
  2. Analyze and interpret CGM reports, identifying critical glucose patterns.
  3. Develop data-driven strategies to optimize glucose management through case-based examples.

Registration
No Registration Fee

Accreditation

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1.00 hour.


ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Tariq Chukir, MD, Thurayya Arayssi, MD, Sohaila Cheema, MBBS, Deema Al-Sheikhly, MRes, MEPH, Christopher Triggle, PhD, Andrew Jones, BSN, Phyllis Sui Muffuh Navti, Doctorate in Pharmacy Practice, Reshma Bholah, MD, Constatina Dalassou, DDS, Devin Thompson, RT, have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Jamie M. Gray, MLS, has disclosed the following relationships: Stocks or Stock Options, excluding diversified mutual funds - Proctor & Gamble, Colgate-Palmolive and Intuitive Surgical Inc

 All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Leena Amine, PharmD, has disclosed the following relationship: Consulting Fee - Wolters Kluwer

All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Faculty: Fatih Gurbuz, MD, has no relevant financial/non-financial relationships with any for-profit /not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products. 


Administrative Contacts: Asha Fernandes, Safia Rabia, have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

ICR: Tariq Chukir, MD, has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.